236 related articles for article (PubMed ID: 33028985)
1. Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages.
Liu QY; Zhuang Y; Song XR; Niu Q; Sun QS; Li XN; Li N; Liu BL; Huang F; Qiu ZX
Acta Pharmacol Sin; 2021 Jun; 42(6):987-997. PubMed ID: 33028985
[TBL] [Abstract][Full Text] [Related]
2. Chicoric acid ameliorates sepsis-induced cardiomyopathy via regulating macrophage metabolism reprogramming.
Sun HJ; Zheng GL; Wang ZC; Liu Y; Bao N; Xiao PX; Lu QB; Zhang JR
Phytomedicine; 2024 Jan; 123():155175. PubMed ID: 37951150
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress.
Li Y; Fu Y; Sun J; Shen J; Liu F; Ning B; Lu Z; Wei L; Jiang X
J Ethnopharmacol; 2022 Jan; 282():114595. PubMed ID: 34517060
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation.
Wen J; Chang Y; Huo S; Li W; Huang H; Gao Y; Lin H; Zhang J; Zhang Y; Zuo Y; Cao X; Zhong F
Aging (Albany NY); 2020 Nov; 13(1):910-932. PubMed ID: 33290264
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages.
Zeng QZ; Yang F; Li CG; Xu LH; He XH; Mai FY; Zeng CY; Zhang CC; Zha QB; Ouyang DY
Front Immunol; 2019; 10():72. PubMed ID: 30761140
[TBL] [Abstract][Full Text] [Related]
6. Silybin inhibits NLRP3 inflammasome assembly through the NAD
Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
[TBL] [Abstract][Full Text] [Related]
7. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.
Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA
Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427
[TBL] [Abstract][Full Text] [Related]
8. Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.
Zhao Q; Bi Y; Guo J; Liu YX; Zhong J; Pan LR; Tan Y; Yu XJ
Acta Pharmacol Sin; 2021 Jun; 42(6):975-986. PubMed ID: 32989235
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA Alleviates Early Brain Injury after Subarachnoid Hemorrhage in Rats by Inhibiting the Activation of NF-κB/NLRP3 Inflammasome.
Yang F; Ma N; Li S; Chen F; Huang X; Zhao L; Cao L
Biol Pharm Bull; 2024 Jan; 47(1):279-291. PubMed ID: 38057100
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
[TBL] [Abstract][Full Text] [Related]
11. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis.
Chen J; Luo W; Hu C; Ren M; Xu H; Xu X; Li W; Chen Y; Shao J; Xiao Z; Lv X; Liang G
Int Immunopharmacol; 2023 May; 118():110065. PubMed ID: 37004347
[TBL] [Abstract][Full Text] [Related]
13. Water extract of Artemisia scoparia Waldst. & Kitam suppresses LPS-induced cytokine production and NLRP3 inflammasome activation in macrophages and alleviates carrageenan-induced acute inflammation in mice.
Ahn JH; Park YL; Song AY; Kim WG; Je CY; Jung DH; Kim YJ; Oh J; Cho JY; Kim DJ; Park JH
J Ethnopharmacol; 2021 Mar; 268():113606. PubMed ID: 33242622
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC.
Zhao J; Liu H; Hong Z; Luo W; Mu W; Hou X; Xu G; Fang Z; Ren L; Liu T; Wen J; Shi W; Wei Z; Yang Y; Zou W; Zhao J; Xiao X; Bai Z; Zhan X
Mol Med; 2023 Jul; 29(1):84. PubMed ID: 37400760
[TBL] [Abstract][Full Text] [Related]
15. Ainsliadimer C, a disesquiterpenoid isolated from Ainsliaea macrocephala, ameliorates inflammatory responses in adipose tissue via Sirtuin 1-NLRP3 inflammasome axis.
Chen C; Ren YM; Zhu JZ; Chen JL; Feng ZL; Zhang T; Ye Y; Lin LG
Acta Pharmacol Sin; 2022 Jul; 43(7):1780-1792. PubMed ID: 34789920
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells.
Jin H; Peng X; He Y; Ruganzu JB; Yang W
Brain Res Bull; 2020 Nov; 164():136-145. PubMed ID: 32860868
[TBL] [Abstract][Full Text] [Related]
17. Chaetocin attenuates gout in mice through inhibiting HIF-1α and NLRP3 inflammasome-dependent IL-1β secretion in macrophages.
Mian Wu ; Zhang M; Ma Y; Liu F; Chen S; Lu J; Chen H
Arch Biochem Biophys; 2019 Jul; 670():94-103. PubMed ID: 31255694
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA prevents acute lung injury by regulating macrophage polarization.
Zhao JY; Pu J; Fan J; Feng XY; Xu JW; Zhang R; Shang Y
J Integr Med; 2022 May; 20(3):274-280. PubMed ID: 35181255
[TBL] [Abstract][Full Text] [Related]
19. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors.
Li J; Zheng Y; Li MX; Yang CW; Liu YF
J Cell Mol Med; 2018 Jan; 22(1):646-654. PubMed ID: 29047214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
